deficit pyruvátdehydrogenázového komplexu [Pyruvate Dehydrogenase Complex Deficiency Disease]

tematický
9
Termíny

ataxie s laktátovou acidózou I
deficit pyruvátdehydrogenázového komplexu, juvenilní forma
deficit pyruvátdehydrogenázového komplexu, neonatální forma
pyruvátdehydrogenasový komplex - nedostatek

 

Ataxia with Lactic Acidosis
Ataxia with Lactic Acidosis I
Ataxia with Lactic Acidosis, Type I
Ataxia, Intermittent, with Abnormal Pyruvate Metabolism
Ataxia, Intermittent, with Pyruvate Dehydrogenase, or Decarboxylase, Deficiency
Intermittent Ataxia with Pyruvate Dehydrogenase Deficiency
Juvenile Pyruvate Dehydrogenase Complex Deficiency Disease
Lactic Acidosis with Ataxia, Type I
Neonatal Pyruvate Dehydrogenase Complex Deficiency Disease
PDH Deficiency
PDHC Deficiency
PDHC Deficiency Disease
Pyruvate Decarboxylase Deficiency
Pyruvate Dehydrogenase Complex Deficiency
Pyruvate Dehydrogenase Complex Deficiency Disease, Juvenile
Pyruvate Dehydrogenase Complex Deficiency Disease, Neonatal
Pyruvate Dehydrogenase Deficiency
Type I Ataxia with Lactic Acidosis

Perzistentní odkaz   https://www.medvik.cz/link/D015325
Definice

Vrozená porucha metabolismu, kdy nedostatečná aktivita pyruvátdehydrogenázového komplexu způsobuje deficit acetylkoenzymu A a snižuje syntézu acetylcholinu. Rozlišuje se neonatální a juvenilní forma nemoci. Neonatální forma je poměrně běžnou příčinou laktátové acidózy v prvních týdnech života a může se také projevit erytematózní vyrážkou. K příznakům juvenilní formy patří laktátová acidóza, alopecie, intermitentní ataxie, křeče a erytematózní vyrážka. Autozomálně recesivní a X-vázané formy onemocnění jsou způsobené mutacemi genů pro tři různé enzymové složky pyruvátdehydrogenázového komplexu. Jedna z mutací genu pro podjednotku E1 alfa na Xp22.2-p22.1 vede k vzniku Leighovy nemoci.

An inherited metabolic disorder caused by deficient enzyme activity in the PYRUVATE DEHYDROGENASE COMPLEX, resulting in deficiency of acetyl CoA and reduced synthesis of acetylcholine. Two clinical forms are recognized: neonatal and juvenile. The neonatal form is a relatively common cause of lactic acidosis in the first weeks of life and may also feature an erythematous rash. The juvenile form presents with lactic acidosis, alopecia, intermittent ATAXIA; SEIZURES; and an erythematous rash. (From J Inherit Metab Dis 1996;19(4):452-62) Autosomal recessive and X-linked forms are caused by mutations in the genes for the three different enzyme components of this multisubunit pyruvate dehydrogenase complex. One of the mutations at Xp22.2-p22.1 in the gene for the E1 alpha component of the complex leads to LEIGH DISEASE.

DUI
D015325 MeSH Prohlížeč
CUI
M0023594
Předchozí užití
Pyruvate Dehydrogenase Complex/deficiency (1974-1988)
Historická pozn.
2000(1989); use PYRUVATE METABOLISM, INBORN ERRORS 1989-1990
Veřejná pozn.
2000; see PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY 1991-1999; see PYRUVATE METABOLISM, INBORN ERRORS 1989-1990

C Nemoci
C10.228.140 nemoci mozku 1 177
C10.228.140.163 metabolické nemoci mozku 84
C10.228.140.163.100.084 adrenoleukodystrofie 41
C10.228.140.163.100.320 galaktosemie 44
C10.228.140.163.100.355 Hartnupova nemoc 2
C10.228.140.163.100.360 hepatolentikulární degenerace 243
C10.228.140.163.100.362 dědičné demyelinizační nemoci CNS 11
C10.228.140.163.100.365 homocystinurie 107
C10.228.140.163.100.375 neketotická hyperglycinemie 7
C10.228.140.163.100.380 hyperlysinemie
C10.228.140.163.100.412 Leighova nemoc 26
C10.228.140.163.100.425 Leschův-Nyhanův syndrom 20
C10.228.140.163.100.520 nemoc s močí javorového sirupu 8
C10.228.140.163.100.535 syndrom MELAS 17
C10.228.140.163.100.540 Menkesova choroba 12
C10.228.140.163.100.545 syndrom MERRF 4
C10.228.140.163.100.593 nedostatek mevalonátkinázy 16
C10.228.140.163.100.640 okulocerebrorenální syndrom 9
C10.228.140.163.100.687 fenylketonurie 285
C10.228.140.163.100.725 nedostatek pyruvátkarboxylázy
C10.228.140.163.100.813 Refsumova nemoc 6
C10.228.140.163.100.844 Refsumova nemoc infantilní
C10.228.140.163.100.875 tyrosinemie 18
C10.228.140.163.100.937 vrozené poruchy cyklu močoviny 7
C10.228.140.163.100.968 Zellwegerův syndrom 10
C10.597.606.360 mentální retardace 1 027
C10.597.606.360.455.124 adrenoleukodystrofie 41
C10.597.606.360.455.249 Coffinův-Lowryho syndrom
C10.597.606.360.455.500 syndrom fragilního X 62
C10.597.606.360.455.562 glykogenóza typu IIb 11
C10.597.606.360.455.625 Leschův-Nyhanův syndrom 20
C10.597.606.360.455.687 Menkesova choroba 12
C10.597.606.360.455.750 mukopolysacharidóza II 25
C10.597.606.360.455.937 Rettův syndrom 52
C16.320.322.500.124 adrenoleukodystrofie 41
C16.320.322.500.249 Coffinův-Lowryho syndrom
C16.320.322.500.500 syndrom fragilního X 62
C16.320.322.500.625 Leschův-Nyhanův syndrom 20
C16.320.322.500.687 Menkesova choroba 12
C16.320.322.500.750 mukopolysacharidóza II 25
C16.320.322.500.937 Rettův syndrom 52
C16.320.400.525.124 adrenoleukodystrofie 41
C16.320.400.525.249 Coffinův-Lowryho syndrom
C16.320.400.525.500 syndrom fragilního X 62
C16.320.400.525.625 Leschův-Nyhanův syndrom 20
C16.320.400.525.687 Menkesova choroba 12
C16.320.400.525.750 mukopolysacharidóza II 25
C16.320.400.525.937 Rettův syndrom 52
C16.320.565.189.084 adrenoleukodystrofie 41
C16.320.565.189.320 galaktosemie 44
C16.320.565.189.355 Hartnupova nemoc 2
C16.320.565.189.360 hepatolentikulární degenerace 243
C16.320.565.189.365 homocystinurie 107
C16.320.565.189.375 neketotická hyperglycinemie 7
C16.320.565.189.380 hyperlysinemie
C16.320.565.189.412 Leighova nemoc 26
C16.320.565.189.425 Leschův-Nyhanův syndrom 20
C16.320.565.189.535 syndrom MELAS 17
C16.320.565.189.540 Menkesova choroba 12
C16.320.565.189.545 syndrom MERRF 4
C16.320.565.189.593 nedostatek mevalonátkinázy 16
C16.320.565.189.640 okulocerebrorenální syndrom 9
C16.320.565.189.687 fenylketonurie 285
C16.320.565.189.813 Refsumova nemoc 6
C16.320.565.189.844 Refsumova nemoc infantilní
C16.320.565.189.875 tyrosinemie 18
C16.320.565.189.968 Zellwegerův syndrom 10
C16.320.565.202.810.444 Leighova nemoc 26
C16.320.565.202.810.666 nedostatek pyruvátkarboxylázy
C18.452 metabolické nemoci 1 196
C18.452.132.100.084 adrenoleukodystrofie 41
C18.452.132.100.320 galaktosemie 44
C18.452.132.100.355 Hartnupova nemoc 2
C18.452.132.100.360 hepatolentikulární degenerace 243
C18.452.132.100.365 homocystinurie 107
C18.452.132.100.375 neketotická hyperglycinemie 7
C18.452.132.100.380 hyperlysinemie
C18.452.132.100.412 Leighova nemoc 26
C18.452.132.100.425 Leschův-Nyhanův syndrom 20
C18.452.132.100.535 syndrom MELAS 17
C18.452.132.100.540 Menkesova choroba 12
C18.452.132.100.545 syndrom MERRF 4
C18.452.132.100.593 nedostatek mevalonátkinázy 16
C18.452.132.100.640 okulocerebrorenální syndrom 9
C18.452.132.100.687 fenylketonurie 285
C18.452.132.100.813 Refsumova nemoc 6
C18.452.132.100.844 Refsumova nemoc infantilní
C18.452.132.100.875 tyrosinemie 18
C18.452.132.100.968 Zellwegerův syndrom 10
C18.452.648.189.084 adrenoleukodystrofie 41
C18.452.648.189.320 galaktosemie 44
C18.452.648.189.355 Hartnupova nemoc 2
C18.452.648.189.360 hepatolentikulární degenerace 243
C18.452.648.189.365 homocystinurie 107
C18.452.648.189.375 neketotická hyperglycinemie 7
C18.452.648.189.380 hyperlysinemie
C18.452.648.189.412 Leighova nemoc 26
C18.452.648.189.425 Leschův-Nyhanův syndrom 20
C18.452.648.189.535 syndrom MELAS 17
C18.452.648.189.540 Menkesova choroba 12
C18.452.648.189.545 syndrom MERRF 4
C18.452.648.189.593 nedostatek mevalonátkinázy 16
C18.452.648.189.640 okulocerebrorenální syndrom 9
C18.452.648.189.687 fenylketonurie 285
C18.452.648.189.813 Refsumova nemoc 6
C18.452.648.189.844 Refsumova nemoc infantilní
C18.452.648.189.875 tyrosinemie 18
C18.452.648.189.968 Zellwegerův syndrom 10
C18.452.648.202.810.444 Leighova nemoc 26
C18.452.648.202.810.666 nedostatek pyruvátkarboxylázy
C18.452.660.300 Friedreichova ataxie 54
C18.452.660.520 Leighova nemoc 26
C18.452.660.560 mitochondriální myopatie 40